Evidence map›Paper›PMID 38841709›Full record

ArticleEClinicalMedicine2024

A multimodal aftercare intervention improves the outcome after kidney transplantation - results of the KTx360° aftercare program using claims data.

Lars Pape, Martina DeZwaan, Mariel Nöhre, Felix Klewitz, Eva Kyaw Tha Tun, Jenny Prüfe, Lena Schiffer, Raoul Gertges, Elisabeth Schieffer, Alexander Albrecht and 14 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Lars PapeDepartment of Pediatrics II, University Hospital of Essen, University of Duisburg-Essen Essen, Germany.
Martina DeZwaanDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
Mariel NöhreDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
Felix KlewitzDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
Eva Kyaw Tha TunDepartment of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
Jenny PrüfeDepartment of Pediatrics II, University Hospital of Essen, University of Duisburg-Essen Essen, Germany.
Lena SchifferDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Raoul GertgesDepartment of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.
Elisabeth SchiefferDepartment of Sports Medicine, Hannover Medical School, Hannover, Germany.
Alexander AlbrechtDepartment of Sports Medicine, Hannover Medical School, Hannover, Germany.
Hedwig Theda BoeckDepartment of Sports Medicine, Hannover Medical School, Hannover, Germany.
Volker KliemNephrology Centre Hannoversch Münden, Germany.
Julia Katharina WolffIGES Institute, Berlin, Germany.
Paul LudolphIGES Institute, Berlin, Germany.
Julia TalamoIGES Institute, Berlin, Germany.
Hans-Dieter NoltingIGES Institute, Berlin, Germany.
Marietta LiebDepartment of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Yesim ErimDepartment of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Helge KrusemarkDepartment of Nephrology and Hypertension, University of Erlangen, Erlangen, Germany.
Olaf GefellerDepartment of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Isabelle KaiserDepartment of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Uwe TegtburDepartment of Sports Medicine, Hannover Medical School, Hannover, Germany.
Mario SchifferDepartment of Nephrology and Hypertension, University of Erlangen, Erlangen, Germany.
KTx360°-Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The after-care treatment project KTx360° aimed to reduce graft failure and mortality after kidney transplantation (KTx). Methods: The study was conducted in the study centers Hannover, Erlangen and Hannoversch Muenden from May 2017 to October 2020 under the trial registration ISRCTN29416382. The program provided a multimodal aftercare program including specialized case management, telemedicine support, psychological and exercise assessments, and interventions. For the analysis of graft failure, which was defined as death, re-transplantation or start of long-term dialysis, we used longitudinal claims data from participating statutory health insurances (SHI) which enabled us to compare participants with controls. To balance covariate distributions between these nonrandomized groups we used propensity score methodology, in particular the inverse probability of treatment weighting (IPTW) approach. Findings: In total, 930 adult participants were recruited at three different transplant centres in Germany, of whom 320 were incident (enrolled within the first year after KTx) and 610 prevalent (enrolled >1 year after KTx) patients. Due to differences in the availability of the claims data, the claims data of 411 participants and 418 controls could be used for the analyses. In the prevalent group we detected a significantly lower risk for graft failure in the study participants compared to the matched controls (HR = 0.13, 95% CI = 0.04-0.39, p = 0.005, n = 389 observations), whereas this difference could not be detected in the incident group (HR = 0.92, 95% CI = 0.54-1.56, p = 0.837, n = 440 observations). Interpretation: Our findings suggest that a multimodal and multidisciplinary aftercare intervention can significantly improve outcome after KTx, specifically in patients later after KTx. For evaluation of effects on these outcome parameters in patients enrolled within the first year after transplantation longer observation times are necessary. Funding: The study was funded by the Global Innovation fund of the Joint Federal Committee of the Federal Republic of Germany, grant number 01NVF16009.

Indexed as

AdherenceCardiovascular riskCase-managementGraft survivalKidney transplantationPhysical activity

Identifiers

PMID38841709
PMCPMC11152610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.